Page last updated: 2024-09-03

mk 0663 and erythromycin estolate

mk 0663 has been researched along with erythromycin estolate in 1 studies

Compound Research Comparison

Studies
(mk 0663)
Trials
(mk 0663)
Recent Studies (post-2010)
(mk 0663)
Studies
(erythromycin estolate)
Trials
(erythromycin estolate)
Recent Studies (post-2010) (erythromycin estolate)
5491732651642613

Protein Interaction Comparison

ProteinTaxonomymk 0663 (IC50)erythromycin estolate (IC50)
Bile salt export pumpHomo sapiens (human)4.1
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.0903
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)4.3652

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1

Other Studies

1 other study(ies) available for mk 0663 and erythromycin estolate

ArticleYear
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010